Ticker: JNJ | Published: 2026-09-18
JNJ drifts higher quietly
JNJ is climbing moderately on low volatility, tracking the broader market's steady gain while a CHMP recommendation for its TECVAYLI drug adds mild positive sentiment without any surprise catalyst.
Sources: https://www.globenewswire.com/news-release/2026/09/18/3364625/0/en/chmp-recommends-approval-of-johnson-johnson-s-tecvayli-teclistamab-in-relapsed-refrac